1. Home
  2. ADMA vs DEI Comparison

ADMA vs DEI Comparison

Compare ADMA & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$9.25

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$10.75

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
DEI
Founded
2004
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2012
2006

Fundamental Metrics

Financial Performance
Metric
ADMA
DEI
Price
$9.25
$10.75
Analyst Decision
Strong Buy
Hold
Analyst Count
4
8
Target Price
$25.67
$12.94
AVG Volume (30 Days)
1.7M
1.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
7.06%
EPS Growth
N/A
N/A
EPS
0.35
N/A
Revenue
$42,219,783.00
$1,003,982,000.00
Revenue This Year
$27.46
$1.70
Revenue Next Year
$22.11
$2.35
P/E Ratio
$27.00
N/A
Revenue Growth
43.85
1.77
52 Week Low
$7.21
$9.04
52 Week High
$20.46
$16.74

Technical Indicators

Market Signals
Indicator
ADMA
DEI
Relative Strength Index (RSI) 49.75 28.34
Support Level $9.23 $9.17
Resistance Level $10.24 $12.68
Average True Range (ATR) 0.24 0.27
MACD -0.04 -0.10
Stochastic Oscillator 26.71 1.92

Price Performance

Historical Comparison
ADMA
DEI

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

Share on Social Networks: